Getinge Ab Class B · OMXSTO:GETI_B
Getinge Ab Class B — Q2 2014 Earnings Presentation
15 slides from Getinge Ab Class B's earnings presentation, Jul 15, 2014
Slide 1: Interim Report Jan-June 2014
GETINGE GROUP Interim Report Jan-June 2014 Johan Malmquist, CEO & Ulf Grunander, CFO July 15", 2014
Slide 2: Trends in organic order intake
Q2 2014 GETINGE GROUP Trends in organic order intake Western Europe 31% 03% 04% 11% 33% 00% 69% 30% USA and Canada 2.0% 38% 01% 22% 03% 14% 58% 16% Rest of the world 10,9% 197% -2.5% 51% -106% 145% -23% -5,5% Total 2.9% 45% 09% -05% 31% 27% 36% 91% Q2 REPORT 2014
Slide 3: Consolidated Results
Q2 2014 GETINGE GROUP Consolidated Results Change % Change % Net sales, SEK million 6 327 6 016 5.2% 11 959 11 680 24% Gross margin 48.7 % 50.5 % 18% 49.0 % 50.4 % 14% Operating cost, SEK 2.338 2.187 69% ~4.592 -4.397 4.4% EBITA before restructuring 905 1 004 -9.9 % 1575 1797 12.4% EBITA margin 14.3
Slide 4: Medical Systems
Q2 2014 GETINGE GROUP Medical Systems Net sales, SEK million 3 299 3 152 47% 6118 5 956 2.7% Gross margin % 55,3 % 56,6 % -1.3 % 55.2 % 59.4 % -4.2 % Onerating cost, SEK 1349 = -1302 3.6% 2.655 -2 590 2.5% EBITA before restructuring 600 598 0.3 % 960 1027 6.5 % EBITA margin 18.2 % 19.0 % -0.8 % 15.7
Slide 5: Medical Systems - Highlights
Q2 2014 GETINGE GROUP Medical Systems - Highlights = Medical Systems strengthens its quality management systems = A provision for quality management systems remediation activities of approximately SEK 800 M was accounted for in the first quarter and during the first six months, SEK 253 M was utilize
Slide 6: Extended Care
Q2 2014 GETINGE GROUP Extended Care Net sales, SEK million 1709 1 660 3.0% 3 404 3381 0.7 % Gross margin % 45.6 % 48.0 % -2.4% 47.2% 48.6 % -14% Operating cost, SEK million -640 -561 14.1% -1 256 -1 120 12.1 % EBITA before restructuring 170 269 -36.8 % 411 564 -27.1% EBITA margin 9.9 % 16.2% 6.3 % 1
Slide 7: Extended Care - Highlights
Q2 2014 Extended Care - Highlights Extended Care strengthened its range of medical beds during the quarter with the Enterprise® 9000 Launch of Sara Combilizer; an innovative means of providing early mobilization to a full standing position for patient treated in an intensive care environment GETINGE
Slide 8: Infection Control
Q2 2014 GETINGE GROUP Infection Control Net sales, SEK million 1 320 1.204 9.6% 2 437 2 343 4.0% Gross margin % 36.4 % 38.0 % -1.6 % 36.0 % 37.9% -1.9% Operating cost, SEK million -349 -322 8.4% -680 -686 -0.9 % EBITA before restructuring 135 137 -1.5% 205 206 -0.5 % EBITA margin 10.2 % 11.4% 1.2% 8
Slide 9: Infection Control - Highlights
Q2 2014 GETINGE GROUP Infection Control - Highlights " The efficiency-enhancement program to improve the business area’s profitability is proceeding as planned. = Negotiations initiated with trade unions to transfer the production of Getinge’s flusher-disinfectors product range from Vaxj6, Sweden, t
Slide 10: Financials Q2
Financials Q2 GETINGE GROUP Cash flow from operation, SEK million 901 843 1 339 1 209 Cash conversion, % 73.1 % 68.0% 93.8 % 57.5 % Net Debt, SEK million 20 415 19691 Equity, SEK million 16 284 14 839 Equity / assets ratio, % 34.7 % 33.7 % Net debt / equity ratio, multiple 1.25 1.33 Q2 REPORT 2014
Slide 11: Outlook
GETINGE GROUP Outlook
Slide 12: Outlook 2014
Outlook 2014 GETINGE GROUP * — Organic revenue growth is expected to be comparable to 2013 levels at approximately 4 %. * Restructuring costs are estimated to amount to approx. SEK 960 M for 2014, of which SEK 799 M is attributable to the costs of consultant support for enhancing the quality managem
Slide 13: Page 13
GETINGE GROUP
Slide 14: Forward-looking Information
GETINGE GROUP Forward-looking Information This document contains forward-looking information based on the current expectations of the Getinge Group’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given th
Slide 15: Getinge Group company description
Getinge Group is a global leading medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge Group has more than 15,000 employees in over 40 countries and generates sales exceeding SEK 25 billion (2013). The Group is d